Dexcom Continuous Glucose Monitoring in Long-term Care

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

April 19, 2021

Primary Completion Date

October 21, 2022

Study Completion Date

October 21, 2022

Conditions
DiabetesDiabetes Mellitus, Type 2
Interventions
DEVICE

Dexcom G6 CGM with GTS

CGM sensor will be placed after consent. Glucose values obtained from the CGM sensor will be sent to the CGM transmitter by Bluetooth technology and Dexcom Share2 software application to a smart phone that serves as an intermediate-transmitting (routing) device. Glucose values from the smart phone will be transmitted wirelessly to a table computer (I-Pad) using the Dexcom Follow application. Information on the CGM will activate an alarm in case of hypoglycemia or hyperglycemia events. Hypoglycemia alarm will be set to \< 85 mg/dl (for prevention for low blood glucose levels). Nursing staff will be instructed to provide 15 grams of carbohydrates in response to a hypoglycemia alarm.The hyperglycemia alarm will be set at 300 mg/dl. If this occurs, the nursing staff will assess clinical status and perform a POC glucose testing to confirm glucose values. If blood glucose (BG) \> 300 mg/dl, nursing staff will communicate the high glucose value to the primary care team.

DIAGNOSTIC_TEST

POC Blood Glucose Test + Blinded CGM

Point of Care (POC) testing before meals and bedtime (standard of care). For the control group, participants will also get a CGM sensor (blinded CGM). CGM alarms are turned off, however if the POC is found to be between \<80 mg/dl by POC, 15 grams of carbohydrates will be given as a preventive measurement for hypoglycemia (standard of care).

Trial Locations (2)

30329

A.G. Rhodes, Atlanta

Emory Wesley Woods Hospital, Atlanta

All Listed Sponsors
collaborator

DexCom, Inc.

INDUSTRY

lead

Emory University

OTHER